Descargar Ebook 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford PDF [ePub Mobi] Gratis, Comprar ebook 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series)
3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford
Descripción - Reseña del editor 3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics.Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award.Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry. Contraportada 3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine. Within clinical pharmacy practice, printing technologies may finally lead to the concept of personalised medicines becoming a reality. This volume aims to be the definitive resource for anyone thinking of developing or using 3D printing technologies in the pharmaceutical sector, with a strong focus on the translation of printing technologies to a clinical setting. This text brings together leading experts to provide extensive information on an array of 3D printing techniques, reviewing the current printing technologies in the pharmaceutical manufacturing supply chain, in particular, highlighting the state-of-the-art applications in medicine and discussing modern drug product manufacture from a regulatory perspective. This book is a highly valuable resource for a range of demographics, including academic researchers and the pharmaceutical industry, providing a comprehensive inventory detailing the current and future applications of 3D printing in pharmaceuticals. Professor Abdul Basit is a Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul's research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. His research has been translated into the design of new technologies and improved disease treatments, many of which have been commercialised. Abdul is also a serial entrepreneur and has filed multiple patents, is the recepient of several research awards and has founded 3 companies (Kuecept, Intract Pharma, FabRx). He further serves as a consultant to many pharmaceutical organisations and is on the advisory boards of scientific journals, healthcare and charitable bodies.Professor Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters, 4 authored books and is the recipient of multiple research awards. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, translating his expertise by co-founding FabRx. Simon is also an expert in the physicochemical characterisation of compounds and formulations with thermal methods and calorimetry. Biografía del autor Abdul W. Basit is Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He leads a large and multidisciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late-stage clinical trials. He has published over 350 papers, book chapters and abstracts and delivered more than 250 invited research presentations. Abdul is also a serial entrepreneur and has filed 25 patents and founded 3 pharmaceutical companies (Kuecept, Intract Pharma, FabRx). Abdul is a frequent speaker at international conferences, serves as a consultant to many pharmaceutical companies and is on the advisory boards of scientific journals, healthcare organisations and charitable bodies. He is the European Editor of the International Journal of Pharmaceutics. Abdul was the recipient of the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS) and is the only non-North American scientist to receive this award. He was also the recipient of the Academy of Pharmaceutical Sciences (APS) award. Simon Gaisford holds a Chair in Pharmaceutics and is Head of the Department of Pharmaceutics at the UCL School of Pharmacy, University College London. He has published 110 papers, 8 book chapters and 4 authored books. His research is focused on novel technologies for manufacturing medicines, particularly using ink-jet printing and 3D printing, and he is an expert in the physico-chemical characterisation of compounds and formulations with thermal methods and calorimetry.
Detalles del Libro
- Name: 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series)
- Autor: Abdul W. Basit,Simon Gaisford
- Categoria: Libros,Libros universitarios y de estudios superiores,Medicina y ciencias de la salud
- Tamaño del archivo: 14 MB
- Tipos de archivo: PDF Document
- Descargada: 456 times
- Idioma: Español
- Archivos de estado: AVAILABLE
Lee un libro 3D Printing of Pharmaceuticals (AAPS Advances in the Pharmaceutical Sciences Series) de Abdul W. Basit,Simon Gaisford libros ebooks
AAPS Advances in the Pharmaceutical Sciences Series ~ The AAPS Advances in the Pharmaceutical Sciences Series, published in partnership with the American Association of Pharmaceutical Scientists, is designed to deliver volumes authored by opinion leaders and authorities from around the globe, addressing innovations in drug research and development, and best practice for scientists and industry professionals in the pharma and biotech industries.
3D Printing of Pharmaceuticals / SpringerLink ~ 3D printing is forecast to revolutionise the pharmaceutical sector, changing the face of medicine development, manufacture and use. Potential applications range from pre-clinical drug development and dosage form design through to the fabrication of functionalised implants and regenerative medicine.
3D Printing of Pharmaceuticals / Abdul Basit / Springer ~ This book is first comprehensive overview of 3D printing technologies in the pharmaceutical industry and is the definitive resource for anyone thinking of developing or using 3D printing technology for pharmaceutical industrial applicationsom single crystals through to complex structures .
3D Printing of Pharmaceuticals AAPS Advances in the ~ 3D Printing of Pharmaceuticals AAPS Advances in the Pharmaceutical Sciences Series 31 , Band 31: : Basit, Abdul W., Gaisford, Simon: Fremdsprachige Bücher
3D Printing Techniques in the Pharmaceutical Sciences ~ Part of the AAPS Advances in the Pharmaceutical Sciences Series book series (AAPS, volume 31) Abstract Additive manufacturing, specifically three-dimensional printing (3DP), has been in use in the manufacture of medical devices for some time, with the FDA recently issuing draft guidance for technical considerations in this regard.
3D Printing of Pharmaceuticals / SpringerLink ~ Abstract. In the new era of medicine, 3D printing technique in pharmaceutical manufacturing has already yielded success. For example, Aprecia ®, an FDA-approved pharmaceutical company, has launched its first approved product which is not only unique because of a novel manufacturing process but also better than conventional compressed tablets. 3D printing is an inexpensive additive .
(PDF) 3D Printing in Pharmaceutical and Medical ~ 3D Printing in Pharmaceutical and Medical Applications . ized medicine expressed e.g. by t he production of small series of. . interest in the 3D P methods in phar maceutica l sciences.
Medical Applications of 3D Printing / SpringerLink ~ The 3D printing arena is ultimately exciting and endless in opportunities with the FDA encouraging the development of science and risk based approaches. This chapter will discuss the existing and future medical applications of 3DP and its potential to revolutionise medical practice.
(PDF) 3D Printing & Pharmaceutical Manufacturing ~ As 3D printing capabilities develop further, safety and regulatory concerns are addressed and the cost of the technology falls, contract manufacturers and pharmaceutical companies that experiment .
HOW 3D PRINTING IS TRANSFORMING THE PHARMACEUTICAL WORLD ~ On-Demand Pharmaceutical Manufacturing. Advances in 3D printing technology could allow for the on-demand manufacturing of pharmaceuticals, allowing for a pharmacy to quickly produce a medication based on demand. It is even possible that a patient could utilize a 3D printer at home to print their drugs as they need them.
3D Printing in Pharmaceutical and Medical Applications ~ Growing demand for customized pharmaceutics and medical devices makes the impact of additive manufacturing increased rapidly in recent years. The 3D printing has become one of the most revolutionary and powerful tool serving as a technology of precise manufacturing of individually developed dosage forms, tissue engineering and disease modeling.
Special Issue "3D Printing of Pharmaceuticals and Drug ~ The 3D printing (3DP) process was patented in 1986, however only in the last decade has it been used for medical applications, as well as being utilized in the fields of prosthetics, bio-fabrication, and pharmaceutical printing. 3DP or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided .
Sci-Hub: устраняя преграды на пути распространения знаний ~ Первый в мире пиратский ресурс, который открыл массовый доступ к десяткам миллионов научных статей
3D printing in pharma / Feature / Chemistry World ~ 3D printing is also starting to make a name for itself in medicine manufacturing. While it’s hard to foresee the wholesale replacement of current tablet manufacturing processes, 3D printing .
(AAPS Advances in the Pharmaceutical Sciences Series 21 ~ (AAPS Advances in the Pharmaceutical Sciences Series 21) Russell Weiner, Marian Kelley (eds.)-Translating Molecular Biomarkers into Clinical Assays _ Techniques and Applications-Springer Internation.pdf - Free ebook download as PDF File (.pdf), Text File (.txt) or read book online for free.
GlaxoSmithKline and the Future of 3D-Printed Pharmaceuticals ~ Accelerating Innovation by 3D Printing Pharmaceuticals. 3D printing also unlocks the ability “to create complex shapes and geometry in order to deliver the drug in a different way,” Wallace says. Manipulating the geometry of a tablet could be used to adjust the drug loading, modify the release, or mask the taste of a medicine.
3D printing in pharmaceutics: A new tool for designing ~ However, in 2007, 3D printing was mostly confined in the world of patents and almost exclusively concerned the continuous inkjet printing process developed by Sachs et al. (1993) at MIT. Therefore, in revisiting the method proposed by Yu et al. in their review, it seemed productive to review again new technologies that have been used in practice in pharmaceuticals.
3D Printing in Pharmaceuticals - LinkedIn SlideShare ~ 3D PRINTING • 3D printing or additive manufacturing is a process of making three dimensional solid objects from a digital file. • 3-D printing is 2D printing—several thousand times, where the printer stacks layers to generate parts. 4. 3D PRINTING • The creation of a 3D printed object is achieved using additive processes.
Scopus ~ Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.
How will 3D printing impact pharmaceutical manufacturing ~ 3D printing has the potential to be a highly disruptive technology when applied to pharmaceutical manufacturing. In addition to enabling the production of more effective dose formats, the technology is likely to play a key part in the pharmaceutical industry’s move towards low-volume production and personalised medicine.
A new chapter in pharmaceutical manufacturing: 3D-printed ~ 3D printing is layer-by-layer production of 3D objects from digital designs. This technology developed at the confluence of chemistry, optics, and robotics research more than 30 years ago to facilitate the creation of prototypes from UV-cured resins .It quickly became a standard tool in the automotive, aerospace, and consumer goods industries.
3d Printing in the Pharmaceutical and Biomedical Industries ~ 3d Printing in the Pharmaceutical and Biomedical Industries Ameya Chaudhari1, Jay Patel2, Suyash Oka3 Manish Jain3 Department of Pharmaceutical Sciences and Technology1, Department of Polymer Science and Technology2, Department of Dyestuff Technology3, . advances in technology have led to 3D printing of .
(PDF) 3D Printing of Pharmaceutical Drug Delivery Systems ~ BACKGROUND: 3D printing technology is a new chapter in pharmaceutical manufacturing and has gained vast interest in the recent past as it offers significant advantages over traditional .
3D printing for chemical, pharmaceutical and biological ~ 3D printing is becoming increasingly prevalent in modern chemistry laboratories. This technology provides chemists with the ability to design, prototype and print functional devices that integrate .
A new chapter in pharmaceutical manufacturing: 3D-printed ~ FDA recently approved a 3D-printed drug product in August 2015, which is indicative of a new chapter for pharmaceutical manufacturing. This review article summarizes progress with 3D printed drug products and discusses process development for solid oral dosage forms.